The estimated Net Worth of Vincent A. Miller is at least $9.25 Миллион dollars as of 22 March 2021. Vincent Miller owns over 3,200 units of Revolution Medicines Inc stock worth over $972,053 and over the last 8 years he sold RVMD stock worth over $8,108,646. In addition, he makes $172,514 as Independent Director at Revolution Medicines Inc.
Sign up
Vincent Miller RVMD stock SEC Form 4 insiders trading
Vincent has made over 21 trades of the Revolution Medicines Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 3,200 units of RVMD stock worth $15,136 on 22 March 2021.
The largest trade he's ever made was selling 32,008 units of Revolution Medicines Inc stock on 20 February 2018 worth over $2,460,455. On average, Vincent trades about 6,180 units every 69 days since 2016. As of 22 March 2021 he still owns at least 23,333 units of Revolution Medicines Inc stock.
You can see the complete history of Vincent Miller stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Vincent Miller biography
Dr. Vincent A. Miller M.D. serves as Independent Director of the Company. Since April 2019, Dr. Miller has served as a Strategic Advisor to Foundation Medicines. Previously, Dr. Miller served as Foundation Medicine’s Senior Vice President, Clinical Development from 2011 to 2013 and served as Foundation Medicine’s Chief Medical Officer from 2013 to April 2019. From 1991 to 2011, Dr. Miller served as an Attending Physician at Memorial Sloan-Kettering Cancer Center. Since 2011, Dr. Miller has served as a Consulting Physician, at Memorial Sloan-Kettering Cancer Center. Dr. Miller received a B.A. from the University of Pennsylvania in Mathematics and an M.D. from the University of Medicine and Dentistry of New Jersey in Newark. Miller’s experience in the biotechnology industry, his extensive experience practicing medicine and his educational background provide him with the qualifications and skills necessary to serve as a member of our board of directors.
What is the salary of Vincent Miller?
As the Independent Director of Revolution Medicines Inc, the total compensation of Vincent Miller at Revolution Medicines Inc is $172,514. There are 12 executives at Revolution Medicines Inc getting paid more, with Mark Goldsmith having the highest compensation of $4,576,250.
How old is Vincent Miller?
Vincent Miller is 57, he's been the Independent Director of Revolution Medicines Inc since 2017. There are 9 older and 8 younger executives at Revolution Medicines Inc. The oldest executive at Revolution Medicines Inc is Elizabeth Anderson, 62, who is the Independent Director.
What's Vincent Miller's mailing address?
Vincent's mailing address filed with the SEC is C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY, CA, 94063.
Insiders trading at Revolution Medicines Inc
Over the last 5 years, insiders at Revolution Medicines Inc have traded over $249,645,422 worth of Revolution Medicines Inc stock and bought 3,371,315 units worth $74,500,278 . The most active insiders traders include Peter Svennilson, Thilo Schroeder и Rock Ventures Ii, L.P.Third.... On average, Revolution Medicines Inc executives and independent directors trade stock every 11 days with the average trade being worth of $3,075,216. The most recent stock trade was executed by Stephen Michael Kelsey on 13 August 2024, trading 16,667 units of RVMD stock currently worth $68,168.
What does Revolution Medicines Inc do?
revolution medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. we pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.
What does Revolution Medicines Inc's logo look like?
Complete history of Vincent Miller stock trades at Revolution Medicines Inc
Revolution Medicines Inc executives and stock owners
Revolution Medicines Inc executives and other stock owners filed with the SEC include:
-
Mark Goldsmith,
Chairman of the Board, President, Chief Executive Officer -
Margaret Horn,
Chief Operating Officer, General Counsel -
Steve Kelsey,
President of Research and Development -
Dr. Mark A. Goldsmith Ph.D.,
CEO, Pres & Chairman -
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D.,
Pres of R&D -
Margaret A. Horn J.D.,
COO, Gen. Counsel & Sec. -
Dr. Stephen M. Kelsey M.D., FRCP, FRC Path.,
Pres of R&D -
Margaret A. Horn,
COO, Gen. Counsel & Sec. -
Xiaolin Wang,
Exec. VP of Clinical Devel. -
Dr. Mark A. Goldsmith M.D., Ph.D.,
CEO, Pres & Chairman -
Alexis Borisy,
Lead Independent Director -
Barbara Weber,
Independent Director -
Vincent Miller,
Independent Director -
Elizabeth Anderson,
Independent Director -
Peter Svennilson,
Independent Director -
Thilo Schroeder,
Independent Director -
Eric Schmidt,
Independent Director -
Neil Exter,
Independent Director -
Jack Anders,
Vice President - Finance and Principal Accounting Officer -
Dr. Martin D. Burke M.D., Ph.D.,
Co-Founder & Chairman of Scientific Advisory Board -
Jack Anders,
Sr. VP of Fin. & Principal Accounting Officer -
Luan M. Wilfong,
Sr. VP of HR -
Walter Reiher Ph.D.,
Chief Information Officer -
David L. Pompliano,
Founding Chief Scientific Officer -
Dr. Kevan M. Shokat,
Academic Co-Founder & Member of Scientific Advisory Board -
Dr. Michael A. Fischbach,
Academic Co-Founder & Member of Scientific Advisory Board -
Dr. Martin D. Burke,
Co-Founder & Chairman of Scientific Advisory Board -
Frank Clyburn,
-
Group Iii, Lpcolumn Group I...,
-
Laurence Lasky,
Director -
Group Iii, Lp Svennilson Pe...,
-
Rock Ventures Iii, L.P.Thir...,
-
Rock Ventures Iv, L.P.Third...,
-
James E Deerfield Mgmt Iv, ...,
-
Lin Wei,
Chief Medical Officer -
Jeff Cislini,
General Counsel -
Stephen Michael Kelsey,
See Remarks -
Rock Ventures Iii, L.P.Thir...,
-
Rock Ventures Iii, L.P.Thir...,
-
Xiaolin Wang,
See Remarks -
Rock Ventures Ii, L.P.Third...,
-
Rock Ventures Iii, L.P.Thir...,
-
Sushil Patel,
-
Flavia Borellini,
-
Lorence H. Kim,